1.World Health Organization. Situation report - 154. Coronavirus disease 2019 (COVID–19). 2020.
2.Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet. 2020.
3.Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020.
4.Lai C-C, Shih T-P, Ko W-C, Tang H-J, Hsuehe P-R. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV–2) and coronavirus disease–2019 (COVID–19): The epidemic and the challenges. Int J Antimicrob Agents. 2020.
5.Lippi G, Mattiuzzi C, Sanchis-Gomar F, Henry BM. Clinical and Demographic Characteristics of Patients Dying From COVID–19 in Italy Versus China. J Med Virol. 2020.
6.Proyecciones de la población de México y de las Entidades Federativas, 2016–2050 [Internet]. 2020. Available from: http://www.conapo.gob.mx.
7.Parra-Rodríguez P, González-Meljem JM, Gómez-Dantés H, Gutiérrez-Robledo H, López-Ortega M, García-Peña C, et al. The Burden of Disease in Mexican Older Adults: Premature Mortality Challenging a Limited-Resource Health System. J Aging Health. 2019;27.
8.Secretaría de Salud. Bases de datos COVID–19. 2020.
9.Meng Y, Wu P, Lu W, Liu K, Ma K, Huang L, et al. Sex-specific clinical characteristics and prognosis of coronavirus disease–19 infection in Wuhan, China: A retrospective study of 168 severe patients. PLoS Pathog. 2020;16(4):e1008520.
10.Wenham C, Smith J, Morgan R, Gender Group C-W. COVID–19: the gendered impacts of the outbreak. Lancet. 2020;395:846–8.
11.Li K, Wu J, Wu F, Guo D, Chen L, Fang Z, et al. The Clinical and Chest CT Features Associated With Severe and Critical COVID–19 Pneumonia. Investigative Radiology. 2020;55(6):327–31.
12.Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID–19 in Wuhan, China: a retrospective cohort study. Lancet. 2020.
13.Zareifopoulos N, Lagadinou M, Karela A, Platanaki C, Karantzogiannis G, Velissaris D. Management of COVID–19: The Risks Associated With Treatment Are Clear, but the Benefits Remain Uncertain. Monaldi Arch Chest Dis. 2020;90(2).
14.Linton NM, Kobayashi T, Yang Y, Hayashi K, Akhmetzhanov AR, Jung S-M, et al. Incubation Period and Other Epidemiological Characteristics of 2019 Novel Coronavirus Infections with Right Truncation: A Statistical Analysis of Publicly Available Case Data. J Clin Med. 2020;9(2):538.
15.Gallagher P, Chan KR, Rivino L, Yacoub S. The association of obesity and severe dengue: possible pathophysiological mechanisms. J Infect Dev Ctries. 2020.
16.Kunnumakkara AB, Sailo BL, Banik K, Harsha C, Prasad S, Gupta SC, et al. Chronic diseases, inflammation, and spices: how are they linked? J Transl Med. 2018;16(1):14.
17.Monteiro R, Azevedo I. Chronic Inflammation in Obesity and the Metabolic Syndrome. Mediators Inflamm. 2010.
18.Chiappetta S, Sharma A, Bottino V, Stier C. COVID–19 and the Role of Chronic Inflammation in Patients With Obesity. International journal of obesity (2005). 2020;14:1–3.
19.Jacob SR, Raveendran R, Kannan S. Causes, Comorbidities and Current Status of Chronic Kidney Disease: A Community Perspective From North Kerala. J Family Med Prim Care. 2019;8(9):2859–63.
20.Garofalo C, Borrell S, Pacilio M, Minutolo R, Chiodini P, De Nicola L, et al. Hypertension and Prehypertension and Prediction of Development of Decreased Estimated GFR in the General Population: A Meta-analysis of Cohort Studies. Am J Kidney Dis. 2015;67(1):89–97.
21.Cheng Y, Luo R, Wang K, Zhang M, Wang Z, Dong L, et al. Kidney disease is associated with in-hospital death of patients with COVID–19. Kidney Int. 2020;97(5):829–38.
22.Lu R, Zhao X, Li J, Niu P, Yang B, Wu H, et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395:556–74.
23.Rabb H. Kidney Diseases in the Time of COVID–19: Major Challenges to Patient Care. J Clin Invest 2020.
24.Chen Y, Zhao M, Wu Y, Zang S. Epidemiological analysis of the early 38 fatalities in Hubei, China, of the coronavirus disease 2019. J Glob Health. 2020;10(1).
25.World Health Organization. Situation report - 103. Coronavirus disease 2019 (COVID–19). 2020.
26.Burki T. COVID–19 in Latin America. Lancet Infect Dis. 2020;20(5):547–8.